Global Next Generation Probiotics Market Growth 2026-2032
The global Next Generation Probiotics market size is predicted to grow from US$ 486 million in 2025 to US$ 929 million in 2032; it is expected to grow at a CAGR of 10.0% from 2026 to 2032.
In 2025, global Next Generation Probiotics production reached approximately 6,206 Tons.The average price is approximately $80,000.Next Generation Probiotics refer to a class of functional microbial products developed based on human microbiome science. These strains are usually derived from the human gut or specific ecological niches and are developed through functional screening, mechanism verification, and engineering to achieve predictable, repeatable, and verifiable health or therapeutic effects.
Gross Profit Margin Levels Currently, there is no unified, publicly available, and comparable ?industry average gross profit margin? in the next-generation probiotic industry. This is because this sector includes prescription LBP/microbial drug companies, consumer-grade NGP brands, and a few manufacturing platform companies, with vastly different business models. Overall, the theoretical gross profit margin of this industry is not low, but the actual gross profit margin in the early stages is often significantly compressed by manufacturing complexity: on the one hand, many key strains are strict anaerobes, requiring extremely high conditions for cultivation, freeze-drying, packaging, and storage and transportation; on the other hand, research has indicated that cGMP production of engineered or highly complex symbiotic bacteria requires specialized anaerobic facilities, and the freeze-drying process can also lead to more than 50% activity loss. Adding to this the costs of GMP workshops, release testing, stability verification, clinical trials, and cold chain/dosage form development, the gross profit margin of prescription or clinical-stage companies before scaling up production is usually not as easily increased as in traditional health supplements. Industry experience shows that the gross profit margin is relatively moderate in the small-batch stage and gradually increases after scaling up production. Consumer-grade high-end NGP brands, due to their higher retail prices (e.g., Pendulum's core products are priced significantly higher than traditional mass-market probiotics), often have higher profit margins at the product level. However, marketing education and user acquisition costs also dilute profits. In summary, I tend to view this sector as follows: prescription/clinical companies are mostly in the ramp-up phase of gross margins, while consumer-grade high-end brands offer better profit margins. However, the key to consistently realizing high profit margins still depends on technological maturity, large-scale manufacturing capabilities, and compliance cost control.
Industry Drivers
The core driving force of the next-generation probiotic industry in the past two years has primarily come from the genuine validation of regulatory and clinical feasibility: the approval of REBYOTA and VOWST signifies that microbiome therapy has moved from the ?proof of concept? stage to the ?regulatory feasibility? stage, which has a significant positive impact on capital, pharmaceutical company collaborations, and supply chain expansion. Secondly, the number of pipelines and the scope of indications are expanding rapidly. IQVIA has pointed out that there are more than 150 microbiome therapy projects in clinical development globally, focusing on infections, immune systems, oncology, and cardiometabolic diseases. This indicates that industry demand is no longer limited to recurrent C. difficile but is extending to the larger market for chronic diseases and adjuvant cancer treatment. Thirdly, advancements in multi-omics, AI-based bacterial screening, functional microbiome alliance design, and standardized manufacturing technologies have significantly improved the feasibility of moving from ?discovering bacteria? to ?making it into a drug/product.? Fourthly, regulatory collaboration and standardization are also strengthening. Organizations such as MTIG have been continuously promoting cross-regional rule harmonization in recent years, which helps reduce uncertainty for companies in CMC, release standards, and clinical development. Finally, the consumer side is also simultaneously benefiting from rising demand for metabolic health, intestinal barrier, and weight management. Representative ?next-generation strains? such as Akkermansia are expanding this sector from pure pharmaceuticals to high-end consumer healthcare, forming a ?dual-engine? growth structure.
LP Information, Inc. (LPI) ' newest research report, the ?Next Generation Probiotics Industry Forecast? looks at past sales and reviews total world Next Generation Probiotics sales in 2025, providing a comprehensive analysis by region and market sector of projected Next Generation Probiotics sales for 2026 through 2032. With Next Generation Probiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next Generation Probiotics industry.
This Insight Report provides a comprehensive analysis of the global Next Generation Probiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Next Generation Probiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Next Generation Probiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next Generation Probiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next Generation Probiotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Next Generation Probiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
In 2025, global Next Generation Probiotics production reached approximately 6,206 Tons.The average price is approximately $80,000.Next Generation Probiotics refer to a class of functional microbial products developed based on human microbiome science. These strains are usually derived from the human gut or specific ecological niches and are developed through functional screening, mechanism verification, and engineering to achieve predictable, repeatable, and verifiable health or therapeutic effects.
Gross Profit Margin Levels Currently, there is no unified, publicly available, and comparable ?industry average gross profit margin? in the next-generation probiotic industry. This is because this sector includes prescription LBP/microbial drug companies, consumer-grade NGP brands, and a few manufacturing platform companies, with vastly different business models. Overall, the theoretical gross profit margin of this industry is not low, but the actual gross profit margin in the early stages is often significantly compressed by manufacturing complexity: on the one hand, many key strains are strict anaerobes, requiring extremely high conditions for cultivation, freeze-drying, packaging, and storage and transportation; on the other hand, research has indicated that cGMP production of engineered or highly complex symbiotic bacteria requires specialized anaerobic facilities, and the freeze-drying process can also lead to more than 50% activity loss. Adding to this the costs of GMP workshops, release testing, stability verification, clinical trials, and cold chain/dosage form development, the gross profit margin of prescription or clinical-stage companies before scaling up production is usually not as easily increased as in traditional health supplements. Industry experience shows that the gross profit margin is relatively moderate in the small-batch stage and gradually increases after scaling up production. Consumer-grade high-end NGP brands, due to their higher retail prices (e.g., Pendulum's core products are priced significantly higher than traditional mass-market probiotics), often have higher profit margins at the product level. However, marketing education and user acquisition costs also dilute profits. In summary, I tend to view this sector as follows: prescription/clinical companies are mostly in the ramp-up phase of gross margins, while consumer-grade high-end brands offer better profit margins. However, the key to consistently realizing high profit margins still depends on technological maturity, large-scale manufacturing capabilities, and compliance cost control.
Industry Drivers
The core driving force of the next-generation probiotic industry in the past two years has primarily come from the genuine validation of regulatory and clinical feasibility: the approval of REBYOTA and VOWST signifies that microbiome therapy has moved from the ?proof of concept? stage to the ?regulatory feasibility? stage, which has a significant positive impact on capital, pharmaceutical company collaborations, and supply chain expansion. Secondly, the number of pipelines and the scope of indications are expanding rapidly. IQVIA has pointed out that there are more than 150 microbiome therapy projects in clinical development globally, focusing on infections, immune systems, oncology, and cardiometabolic diseases. This indicates that industry demand is no longer limited to recurrent C. difficile but is extending to the larger market for chronic diseases and adjuvant cancer treatment. Thirdly, advancements in multi-omics, AI-based bacterial screening, functional microbiome alliance design, and standardized manufacturing technologies have significantly improved the feasibility of moving from ?discovering bacteria? to ?making it into a drug/product.? Fourthly, regulatory collaboration and standardization are also strengthening. Organizations such as MTIG have been continuously promoting cross-regional rule harmonization in recent years, which helps reduce uncertainty for companies in CMC, release standards, and clinical development. Finally, the consumer side is also simultaneously benefiting from rising demand for metabolic health, intestinal barrier, and weight management. Representative ?next-generation strains? such as Akkermansia are expanding this sector from pure pharmaceuticals to high-end consumer healthcare, forming a ?dual-engine? growth structure.
LP Information, Inc. (LPI) ' newest research report, the ?Next Generation Probiotics Industry Forecast? looks at past sales and reviews total world Next Generation Probiotics sales in 2025, providing a comprehensive analysis by region and market sector of projected Next Generation Probiotics sales for 2026 through 2032. With Next Generation Probiotics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next Generation Probiotics industry.
This Insight Report provides a comprehensive analysis of the global Next Generation Probiotics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Next Generation Probiotics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Next Generation Probiotics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next Generation Probiotics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next Generation Probiotics.
This report presents a comprehensive overview, market shares, and growth opportunities of Next Generation Probiotics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Akkermansia
- Clostridium Species
- Bifidobacterium Species
- Others
- Live NGP
- Inactivated NGP
- Others
- Metabolic Health Targeted Therapy
- Intestinal Inflammation Targeted Therapy
- Immune Regulation Targeted Therapy
- Others
- Pharmaceuticals and Biotherapy Industry
- Dietary Supplements and Functional Foods Industry
- Food and Beverage Industry
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Seres Therapeutics (USA)
- Ferring Pharmaceuticals (Switzerland)
- Vedanta Biosciences (USA)
- Enterome (France)
- 4D Pharma (UK)
- Second Genome (USA)
- AOBiome (USA)
- Finch Therapeutics (USA)
- MaaT Pharma (France)
- BioGaia (Sweden)
- Yakult Honsha (Japan)
- Morinaga Milk Industry (Japan)
- DuPont (USA)
- Chr. Hansen (Denmark)
- Lallemand (Canada)
- Probi (Sweden)
- Novozymes (Denmark)
- Kerry Group (Ireland)
- ADM (USA)
- BGI Genomics (China)
- Joinn Laboratories (China)
- Jiangsu Wecare Probiotics (China)
- Angel Yeast (China)
- Evelo Biosciences (USA)
- BIFIDO (South Korea)
- Cell Biotech (South Korea)
- Synlogic (USA)
- What is the 10-year outlook for the global Next Generation Probiotics market?
- What factors are driving Next Generation Probiotics market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doNext Generation Probiotics market opportunities vary by end market size?
- How does Next Generation Probiotics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Next Generation Probiotics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Next Generation Probiotics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Next Generation Probiotics by Country/Region, 2021, 2025 & 2032
2.2 Next Generation Probiotics Segment by Type
2.2.1 Akkermansia
2.2.2 Clostridium Species
2.2.3 Bifidobacterium Species
2.2.4 Others
2.2.5 Next Generation Probiotics Sales by Type
2.2.5.1 Global Next Generation Probiotics Sales Market Share by Type (2021-2026)
2.2.5.2 Global Next Generation Probiotics Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Next Generation Probiotics Sale Price by Type (2021-2026)
2.3 Next Generation Probiotics Segment by Live Bacteria Status
2.3.1 Live NGP
2.3.2 Inactivated NGP
2.3.3 Others
2.3.4 Next Generation Probiotics Sales by Live Bacteria Status
2.3.4.1 Global Next Generation Probiotics Sales Market Share by Live Bacteria Status (2021-2026)
2.3.4.2 Global Next Generation Probiotics Revenue and Market Share by Live Bacteria Status (2021-2026)
2.3.4.3 Global Next Generation Probiotics Sale Price by Live Bacteria Status (2021-2026)
2.4 Next Generation Probiotics Segment by Core Functional Targeting Dimensions
2.4.1 Metabolic Health Targeted Therapy
2.4.2 Intestinal Inflammation Targeted Therapy
2.4.3 Immune Regulation Targeted Therapy
2.4.4 Others
2.4.5 Next Generation Probiotics Sales by Core Functional Targeting Dimensions
2.4.5.1 Global Next Generation Probiotics Sales Market Share by Core Functional Targeting Dimensions (2021-2026)
2.4.5.2 Global Next Generation Probiotics Revenue and Market Share by Core Functional Targeting Dimensions (2021-2026)
2.4.5.3 Global Next Generation Probiotics Sale Price by Core Functional Targeting Dimensions (2021-2026)
2.5 Next Generation Probiotics Segment by Application
2.5.1 Pharmaceuticals and Biotherapy Industry
2.5.2 Dietary Supplements and Functional Foods Industry
2.5.3 Food and Beverage Industry
2.5.4 Others
2.5.5 Next Generation Probiotics Sales by Application
2.5.5.1 Global Next Generation Probiotics Sale Market Share by Application (2021-2026)
2.5.5.2 Global Next Generation Probiotics Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Next Generation Probiotics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Next Generation Probiotics Breakdown Data by Company
3.1.1 Global Next Generation Probiotics Annual Sales by Company (2021-2026)
3.1.2 Global Next Generation Probiotics Sales Market Share by Company (2021-2026)
3.2 Global Next Generation Probiotics Annual Revenue by Company (2021-2026)
3.2.1 Global Next Generation Probiotics Revenue by Company (2021-2026)
3.2.2 Global Next Generation Probiotics Revenue Market Share by Company (2021-2026)
3.3 Global Next Generation Probiotics Sale Price by Company
3.4 Key Manufacturers Next Generation Probiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Next Generation Probiotics Product Location Distribution
3.4.2 Players Next Generation Probiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEXT GENERATION PROBIOTICS BY GEOGRAPHIC REGION
4.1 World Historic Next Generation Probiotics Market Size by Geographic Region (2021-2026)
4.1.1 Global Next Generation Probiotics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Next Generation Probiotics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Next Generation Probiotics Market Size by Country/Region (2021-2026)
4.2.1 Global Next Generation Probiotics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Next Generation Probiotics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Next Generation Probiotics Sales Growth
4.4 APAC Next Generation Probiotics Sales Growth
4.5 Europe Next Generation Probiotics Sales Growth
4.6 Middle East & Africa Next Generation Probiotics Sales Growth
5 AMERICAS
5.1 Americas Next Generation Probiotics Sales by Country
5.1.1 Americas Next Generation Probiotics Sales by Country (2021-2026)
5.1.2 Americas Next Generation Probiotics Revenue by Country (2021-2026)
5.2 Americas Next Generation Probiotics Sales by Type (2021-2026)
5.3 Americas Next Generation Probiotics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next Generation Probiotics Sales by Region
6.1.1 APAC Next Generation Probiotics Sales by Region (2021-2026)
6.1.2 APAC Next Generation Probiotics Revenue by Region (2021-2026)
6.2 APAC Next Generation Probiotics Sales by Type (2021-2026)
6.3 APAC Next Generation Probiotics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Next Generation Probiotics by Country
7.1.1 Europe Next Generation Probiotics Sales by Country (2021-2026)
7.1.2 Europe Next Generation Probiotics Revenue by Country (2021-2026)
7.2 Europe Next Generation Probiotics Sales by Type (2021-2026)
7.3 Europe Next Generation Probiotics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Next Generation Probiotics by Country
8.1.1 Middle East & Africa Next Generation Probiotics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Next Generation Probiotics Revenue by Country (2021-2026)
8.2 Middle East & Africa Next Generation Probiotics Sales by Type (2021-2026)
8.3 Middle East & Africa Next Generation Probiotics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Next Generation Probiotics
10.3 Manufacturing Process Analysis of Next Generation Probiotics
10.4 Industry Chain Structure of Next Generation Probiotics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Next Generation Probiotics Distributors
11.3 Next Generation Probiotics Customer
12 WORLD FORECAST REVIEW FOR NEXT GENERATION PROBIOTICS BY GEOGRAPHIC REGION
12.1 Global Next Generation Probiotics Market Size Forecast by Region
12.1.1 Global Next Generation Probiotics Forecast by Region (2027-2032)
12.1.2 Global Next Generation Probiotics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Next Generation Probiotics Forecast by Type (2027-2032)
12.7 Global Next Generation Probiotics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Seres Therapeutics (USA)
13.1.1 Seres Therapeutics (USA) Company Information
13.1.2 Seres Therapeutics (USA) Next Generation Probiotics Product Portfolios and Specifications
13.1.3 Seres Therapeutics (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Seres Therapeutics (USA) Main Business Overview
13.1.5 Seres Therapeutics (USA) Latest Developments
13.2 Ferring Pharmaceuticals (Switzerland)
13.2.1 Ferring Pharmaceuticals (Switzerland) Company Information
13.2.2 Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Product Portfolios and Specifications
13.2.3 Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ferring Pharmaceuticals (Switzerland) Main Business Overview
13.2.5 Ferring Pharmaceuticals (Switzerland) Latest Developments
13.3 Vedanta Biosciences (USA)
13.3.1 Vedanta Biosciences (USA) Company Information
13.3.2 Vedanta Biosciences (USA) Next Generation Probiotics Product Portfolios and Specifications
13.3.3 Vedanta Biosciences (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Vedanta Biosciences (USA) Main Business Overview
13.3.5 Vedanta Biosciences (USA) Latest Developments
13.4 Enterome (France)
13.4.1 Enterome (France) Company Information
13.4.2 Enterome (France) Next Generation Probiotics Product Portfolios and Specifications
13.4.3 Enterome (France) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Enterome (France) Main Business Overview
13.4.5 Enterome (France) Latest Developments
13.5 4D Pharma (UK)
13.5.1 4D Pharma (UK) Company Information
13.5.2 4D Pharma (UK) Next Generation Probiotics Product Portfolios and Specifications
13.5.3 4D Pharma (UK) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 4D Pharma (UK) Main Business Overview
13.5.5 4D Pharma (UK) Latest Developments
13.6 Second Genome (USA)
13.6.1 Second Genome (USA) Company Information
13.6.2 Second Genome (USA) Next Generation Probiotics Product Portfolios and Specifications
13.6.3 Second Genome (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Second Genome (USA) Main Business Overview
13.6.5 Second Genome (USA) Latest Developments
13.7 AOBiome (USA)
13.7.1 AOBiome (USA) Company Information
13.7.2 AOBiome (USA) Next Generation Probiotics Product Portfolios and Specifications
13.7.3 AOBiome (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AOBiome (USA) Main Business Overview
13.7.5 AOBiome (USA) Latest Developments
13.8 Finch Therapeutics (USA)
13.8.1 Finch Therapeutics (USA) Company Information
13.8.2 Finch Therapeutics (USA) Next Generation Probiotics Product Portfolios and Specifications
13.8.3 Finch Therapeutics (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Finch Therapeutics (USA) Main Business Overview
13.8.5 Finch Therapeutics (USA) Latest Developments
13.9 MaaT Pharma (France)
13.9.1 MaaT Pharma (France) Company Information
13.9.2 MaaT Pharma (France) Next Generation Probiotics Product Portfolios and Specifications
13.9.3 MaaT Pharma (France) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 MaaT Pharma (France) Main Business Overview
13.9.5 MaaT Pharma (France) Latest Developments
13.10 BioGaia (Sweden)
13.10.1 BioGaia (Sweden) Company Information
13.10.2 BioGaia (Sweden) Next Generation Probiotics Product Portfolios and Specifications
13.10.3 BioGaia (Sweden) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 BioGaia (Sweden) Main Business Overview
13.10.5 BioGaia (Sweden) Latest Developments
13.11 Yakult Honsha (Japan)
13.11.1 Yakult Honsha (Japan) Company Information
13.11.2 Yakult Honsha (Japan) Next Generation Probiotics Product Portfolios and Specifications
13.11.3 Yakult Honsha (Japan) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Yakult Honsha (Japan) Main Business Overview
13.11.5 Yakult Honsha (Japan) Latest Developments
13.12 Morinaga Milk Industry (Japan)
13.12.1 Morinaga Milk Industry (Japan) Company Information
13.12.2 Morinaga Milk Industry (Japan) Next Generation Probiotics Product Portfolios and Specifications
13.12.3 Morinaga Milk Industry (Japan) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Morinaga Milk Industry (Japan) Main Business Overview
13.12.5 Morinaga Milk Industry (Japan) Latest Developments
13.13 DuPont (USA)
13.13.1 DuPont (USA) Company Information
13.13.2 DuPont (USA) Next Generation Probiotics Product Portfolios and Specifications
13.13.3 DuPont (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 DuPont (USA) Main Business Overview
13.13.5 DuPont (USA) Latest Developments
13.14 Chr. Hansen (Denmark)
13.14.1 Chr. Hansen (Denmark) Company Information
13.14.2 Chr. Hansen (Denmark) Next Generation Probiotics Product Portfolios and Specifications
13.14.3 Chr. Hansen (Denmark) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Chr. Hansen (Denmark) Main Business Overview
13.14.5 Chr. Hansen (Denmark) Latest Developments
13.15 Lallemand (Canada)
13.15.1 Lallemand (Canada) Company Information
13.15.2 Lallemand (Canada) Next Generation Probiotics Product Portfolios and Specifications
13.15.3 Lallemand (Canada) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Lallemand (Canada) Main Business Overview
13.15.5 Lallemand (Canada) Latest Developments
13.16 Probi (Sweden)
13.16.1 Probi (Sweden) Company Information
13.16.2 Probi (Sweden) Next Generation Probiotics Product Portfolios and Specifications
13.16.3 Probi (Sweden) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Probi (Sweden) Main Business Overview
13.16.5 Probi (Sweden) Latest Developments
13.17 Novozymes (Denmark)
13.17.1 Novozymes (Denmark) Company Information
13.17.2 Novozymes (Denmark) Next Generation Probiotics Product Portfolios and Specifications
13.17.3 Novozymes (Denmark) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Novozymes (Denmark) Main Business Overview
13.17.5 Novozymes (Denmark) Latest Developments
13.18 Kerry Group (Ireland)
13.18.1 Kerry Group (Ireland) Company Information
13.18.2 Kerry Group (Ireland) Next Generation Probiotics Product Portfolios and Specifications
13.18.3 Kerry Group (Ireland) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Kerry Group (Ireland) Main Business Overview
13.18.5 Kerry Group (Ireland) Latest Developments
13.19 ADM (USA)
13.19.1 ADM (USA) Company Information
13.19.2 ADM (USA) Next Generation Probiotics Product Portfolios and Specifications
13.19.3 ADM (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 ADM (USA) Main Business Overview
13.19.5 ADM (USA) Latest Developments
13.20 BGI Genomics (China)
13.20.1 BGI Genomics (China) Company Information
13.20.2 BGI Genomics (China) Next Generation Probiotics Product Portfolios and Specifications
13.20.3 BGI Genomics (China) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 BGI Genomics (China) Main Business Overview
13.20.5 BGI Genomics (China) Latest Developments
13.21 Joinn Laboratories (China)
13.21.1 Joinn Laboratories (China) Company Information
13.21.2 Joinn Laboratories (China) Next Generation Probiotics Product Portfolios and Specifications
13.21.3 Joinn Laboratories (China) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Joinn Laboratories (China) Main Business Overview
13.21.5 Joinn Laboratories (China) Latest Developments
13.22 Jiangsu Wecare Probiotics (China)
13.22.1 Jiangsu Wecare Probiotics (China) Company Information
13.22.2 Jiangsu Wecare Probiotics (China) Next Generation Probiotics Product Portfolios and Specifications
13.22.3 Jiangsu Wecare Probiotics (China) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Jiangsu Wecare Probiotics (China) Main Business Overview
13.22.5 Jiangsu Wecare Probiotics (China) Latest Developments
13.23 Angel Yeast (China)
13.23.1 Angel Yeast (China) Company Information
13.23.2 Angel Yeast (China) Next Generation Probiotics Product Portfolios and Specifications
13.23.3 Angel Yeast (China) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Angel Yeast (China) Main Business Overview
13.23.5 Angel Yeast (China) Latest Developments
13.24 Evelo Biosciences (USA)
13.24.1 Evelo Biosciences (USA) Company Information
13.24.2 Evelo Biosciences (USA) Next Generation Probiotics Product Portfolios and Specifications
13.24.3 Evelo Biosciences (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Evelo Biosciences (USA) Main Business Overview
13.24.5 Evelo Biosciences (USA) Latest Developments
13.25 BIFIDO (South Korea)
13.25.1 BIFIDO (South Korea) Company Information
13.25.2 BIFIDO (South Korea) Next Generation Probiotics Product Portfolios and Specifications
13.25.3 BIFIDO (South Korea) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 BIFIDO (South Korea) Main Business Overview
13.25.5 BIFIDO (South Korea) Latest Developments
13.26 Cell Biotech (South Korea)
13.26.1 Cell Biotech (South Korea) Company Information
13.26.2 Cell Biotech (South Korea) Next Generation Probiotics Product Portfolios and Specifications
13.26.3 Cell Biotech (South Korea) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Cell Biotech (South Korea) Main Business Overview
13.26.5 Cell Biotech (South Korea) Latest Developments
13.27 Synlogic (USA)
13.27.1 Synlogic (USA) Company Information
13.27.2 Synlogic (USA) Next Generation Probiotics Product Portfolios and Specifications
13.27.3 Synlogic (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Synlogic (USA) Main Business Overview
13.27.5 Synlogic (USA) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Next Generation Probiotics Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Next Generation Probiotics by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Next Generation Probiotics by Country/Region, 2021, 2025 & 2032
2.2 Next Generation Probiotics Segment by Type
2.2.1 Akkermansia
2.2.2 Clostridium Species
2.2.3 Bifidobacterium Species
2.2.4 Others
2.2.5 Next Generation Probiotics Sales by Type
2.2.5.1 Global Next Generation Probiotics Sales Market Share by Type (2021-2026)
2.2.5.2 Global Next Generation Probiotics Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Next Generation Probiotics Sale Price by Type (2021-2026)
2.3 Next Generation Probiotics Segment by Live Bacteria Status
2.3.1 Live NGP
2.3.2 Inactivated NGP
2.3.3 Others
2.3.4 Next Generation Probiotics Sales by Live Bacteria Status
2.3.4.1 Global Next Generation Probiotics Sales Market Share by Live Bacteria Status (2021-2026)
2.3.4.2 Global Next Generation Probiotics Revenue and Market Share by Live Bacteria Status (2021-2026)
2.3.4.3 Global Next Generation Probiotics Sale Price by Live Bacteria Status (2021-2026)
2.4 Next Generation Probiotics Segment by Core Functional Targeting Dimensions
2.4.1 Metabolic Health Targeted Therapy
2.4.2 Intestinal Inflammation Targeted Therapy
2.4.3 Immune Regulation Targeted Therapy
2.4.4 Others
2.4.5 Next Generation Probiotics Sales by Core Functional Targeting Dimensions
2.4.5.1 Global Next Generation Probiotics Sales Market Share by Core Functional Targeting Dimensions (2021-2026)
2.4.5.2 Global Next Generation Probiotics Revenue and Market Share by Core Functional Targeting Dimensions (2021-2026)
2.4.5.3 Global Next Generation Probiotics Sale Price by Core Functional Targeting Dimensions (2021-2026)
2.5 Next Generation Probiotics Segment by Application
2.5.1 Pharmaceuticals and Biotherapy Industry
2.5.2 Dietary Supplements and Functional Foods Industry
2.5.3 Food and Beverage Industry
2.5.4 Others
2.5.5 Next Generation Probiotics Sales by Application
2.5.5.1 Global Next Generation Probiotics Sale Market Share by Application (2021-2026)
2.5.5.2 Global Next Generation Probiotics Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Next Generation Probiotics Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Next Generation Probiotics Breakdown Data by Company
3.1.1 Global Next Generation Probiotics Annual Sales by Company (2021-2026)
3.1.2 Global Next Generation Probiotics Sales Market Share by Company (2021-2026)
3.2 Global Next Generation Probiotics Annual Revenue by Company (2021-2026)
3.2.1 Global Next Generation Probiotics Revenue by Company (2021-2026)
3.2.2 Global Next Generation Probiotics Revenue Market Share by Company (2021-2026)
3.3 Global Next Generation Probiotics Sale Price by Company
3.4 Key Manufacturers Next Generation Probiotics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Next Generation Probiotics Product Location Distribution
3.4.2 Players Next Generation Probiotics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEXT GENERATION PROBIOTICS BY GEOGRAPHIC REGION
4.1 World Historic Next Generation Probiotics Market Size by Geographic Region (2021-2026)
4.1.1 Global Next Generation Probiotics Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Next Generation Probiotics Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Next Generation Probiotics Market Size by Country/Region (2021-2026)
4.2.1 Global Next Generation Probiotics Annual Sales by Country/Region (2021-2026)
4.2.2 Global Next Generation Probiotics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Next Generation Probiotics Sales Growth
4.4 APAC Next Generation Probiotics Sales Growth
4.5 Europe Next Generation Probiotics Sales Growth
4.6 Middle East & Africa Next Generation Probiotics Sales Growth
5 AMERICAS
5.1 Americas Next Generation Probiotics Sales by Country
5.1.1 Americas Next Generation Probiotics Sales by Country (2021-2026)
5.1.2 Americas Next Generation Probiotics Revenue by Country (2021-2026)
5.2 Americas Next Generation Probiotics Sales by Type (2021-2026)
5.3 Americas Next Generation Probiotics Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Next Generation Probiotics Sales by Region
6.1.1 APAC Next Generation Probiotics Sales by Region (2021-2026)
6.1.2 APAC Next Generation Probiotics Revenue by Region (2021-2026)
6.2 APAC Next Generation Probiotics Sales by Type (2021-2026)
6.3 APAC Next Generation Probiotics Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Next Generation Probiotics by Country
7.1.1 Europe Next Generation Probiotics Sales by Country (2021-2026)
7.1.2 Europe Next Generation Probiotics Revenue by Country (2021-2026)
7.2 Europe Next Generation Probiotics Sales by Type (2021-2026)
7.3 Europe Next Generation Probiotics Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Next Generation Probiotics by Country
8.1.1 Middle East & Africa Next Generation Probiotics Sales by Country (2021-2026)
8.1.2 Middle East & Africa Next Generation Probiotics Revenue by Country (2021-2026)
8.2 Middle East & Africa Next Generation Probiotics Sales by Type (2021-2026)
8.3 Middle East & Africa Next Generation Probiotics Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Next Generation Probiotics
10.3 Manufacturing Process Analysis of Next Generation Probiotics
10.4 Industry Chain Structure of Next Generation Probiotics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Next Generation Probiotics Distributors
11.3 Next Generation Probiotics Customer
12 WORLD FORECAST REVIEW FOR NEXT GENERATION PROBIOTICS BY GEOGRAPHIC REGION
12.1 Global Next Generation Probiotics Market Size Forecast by Region
12.1.1 Global Next Generation Probiotics Forecast by Region (2027-2032)
12.1.2 Global Next Generation Probiotics Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Next Generation Probiotics Forecast by Type (2027-2032)
12.7 Global Next Generation Probiotics Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Seres Therapeutics (USA)
13.1.1 Seres Therapeutics (USA) Company Information
13.1.2 Seres Therapeutics (USA) Next Generation Probiotics Product Portfolios and Specifications
13.1.3 Seres Therapeutics (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Seres Therapeutics (USA) Main Business Overview
13.1.5 Seres Therapeutics (USA) Latest Developments
13.2 Ferring Pharmaceuticals (Switzerland)
13.2.1 Ferring Pharmaceuticals (Switzerland) Company Information
13.2.2 Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Product Portfolios and Specifications
13.2.3 Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ferring Pharmaceuticals (Switzerland) Main Business Overview
13.2.5 Ferring Pharmaceuticals (Switzerland) Latest Developments
13.3 Vedanta Biosciences (USA)
13.3.1 Vedanta Biosciences (USA) Company Information
13.3.2 Vedanta Biosciences (USA) Next Generation Probiotics Product Portfolios and Specifications
13.3.3 Vedanta Biosciences (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Vedanta Biosciences (USA) Main Business Overview
13.3.5 Vedanta Biosciences (USA) Latest Developments
13.4 Enterome (France)
13.4.1 Enterome (France) Company Information
13.4.2 Enterome (France) Next Generation Probiotics Product Portfolios and Specifications
13.4.3 Enterome (France) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Enterome (France) Main Business Overview
13.4.5 Enterome (France) Latest Developments
13.5 4D Pharma (UK)
13.5.1 4D Pharma (UK) Company Information
13.5.2 4D Pharma (UK) Next Generation Probiotics Product Portfolios and Specifications
13.5.3 4D Pharma (UK) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 4D Pharma (UK) Main Business Overview
13.5.5 4D Pharma (UK) Latest Developments
13.6 Second Genome (USA)
13.6.1 Second Genome (USA) Company Information
13.6.2 Second Genome (USA) Next Generation Probiotics Product Portfolios and Specifications
13.6.3 Second Genome (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Second Genome (USA) Main Business Overview
13.6.5 Second Genome (USA) Latest Developments
13.7 AOBiome (USA)
13.7.1 AOBiome (USA) Company Information
13.7.2 AOBiome (USA) Next Generation Probiotics Product Portfolios and Specifications
13.7.3 AOBiome (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AOBiome (USA) Main Business Overview
13.7.5 AOBiome (USA) Latest Developments
13.8 Finch Therapeutics (USA)
13.8.1 Finch Therapeutics (USA) Company Information
13.8.2 Finch Therapeutics (USA) Next Generation Probiotics Product Portfolios and Specifications
13.8.3 Finch Therapeutics (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Finch Therapeutics (USA) Main Business Overview
13.8.5 Finch Therapeutics (USA) Latest Developments
13.9 MaaT Pharma (France)
13.9.1 MaaT Pharma (France) Company Information
13.9.2 MaaT Pharma (France) Next Generation Probiotics Product Portfolios and Specifications
13.9.3 MaaT Pharma (France) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 MaaT Pharma (France) Main Business Overview
13.9.5 MaaT Pharma (France) Latest Developments
13.10 BioGaia (Sweden)
13.10.1 BioGaia (Sweden) Company Information
13.10.2 BioGaia (Sweden) Next Generation Probiotics Product Portfolios and Specifications
13.10.3 BioGaia (Sweden) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 BioGaia (Sweden) Main Business Overview
13.10.5 BioGaia (Sweden) Latest Developments
13.11 Yakult Honsha (Japan)
13.11.1 Yakult Honsha (Japan) Company Information
13.11.2 Yakult Honsha (Japan) Next Generation Probiotics Product Portfolios and Specifications
13.11.3 Yakult Honsha (Japan) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Yakult Honsha (Japan) Main Business Overview
13.11.5 Yakult Honsha (Japan) Latest Developments
13.12 Morinaga Milk Industry (Japan)
13.12.1 Morinaga Milk Industry (Japan) Company Information
13.12.2 Morinaga Milk Industry (Japan) Next Generation Probiotics Product Portfolios and Specifications
13.12.3 Morinaga Milk Industry (Japan) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Morinaga Milk Industry (Japan) Main Business Overview
13.12.5 Morinaga Milk Industry (Japan) Latest Developments
13.13 DuPont (USA)
13.13.1 DuPont (USA) Company Information
13.13.2 DuPont (USA) Next Generation Probiotics Product Portfolios and Specifications
13.13.3 DuPont (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 DuPont (USA) Main Business Overview
13.13.5 DuPont (USA) Latest Developments
13.14 Chr. Hansen (Denmark)
13.14.1 Chr. Hansen (Denmark) Company Information
13.14.2 Chr. Hansen (Denmark) Next Generation Probiotics Product Portfolios and Specifications
13.14.3 Chr. Hansen (Denmark) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Chr. Hansen (Denmark) Main Business Overview
13.14.5 Chr. Hansen (Denmark) Latest Developments
13.15 Lallemand (Canada)
13.15.1 Lallemand (Canada) Company Information
13.15.2 Lallemand (Canada) Next Generation Probiotics Product Portfolios and Specifications
13.15.3 Lallemand (Canada) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Lallemand (Canada) Main Business Overview
13.15.5 Lallemand (Canada) Latest Developments
13.16 Probi (Sweden)
13.16.1 Probi (Sweden) Company Information
13.16.2 Probi (Sweden) Next Generation Probiotics Product Portfolios and Specifications
13.16.3 Probi (Sweden) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Probi (Sweden) Main Business Overview
13.16.5 Probi (Sweden) Latest Developments
13.17 Novozymes (Denmark)
13.17.1 Novozymes (Denmark) Company Information
13.17.2 Novozymes (Denmark) Next Generation Probiotics Product Portfolios and Specifications
13.17.3 Novozymes (Denmark) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Novozymes (Denmark) Main Business Overview
13.17.5 Novozymes (Denmark) Latest Developments
13.18 Kerry Group (Ireland)
13.18.1 Kerry Group (Ireland) Company Information
13.18.2 Kerry Group (Ireland) Next Generation Probiotics Product Portfolios and Specifications
13.18.3 Kerry Group (Ireland) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Kerry Group (Ireland) Main Business Overview
13.18.5 Kerry Group (Ireland) Latest Developments
13.19 ADM (USA)
13.19.1 ADM (USA) Company Information
13.19.2 ADM (USA) Next Generation Probiotics Product Portfolios and Specifications
13.19.3 ADM (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 ADM (USA) Main Business Overview
13.19.5 ADM (USA) Latest Developments
13.20 BGI Genomics (China)
13.20.1 BGI Genomics (China) Company Information
13.20.2 BGI Genomics (China) Next Generation Probiotics Product Portfolios and Specifications
13.20.3 BGI Genomics (China) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 BGI Genomics (China) Main Business Overview
13.20.5 BGI Genomics (China) Latest Developments
13.21 Joinn Laboratories (China)
13.21.1 Joinn Laboratories (China) Company Information
13.21.2 Joinn Laboratories (China) Next Generation Probiotics Product Portfolios and Specifications
13.21.3 Joinn Laboratories (China) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Joinn Laboratories (China) Main Business Overview
13.21.5 Joinn Laboratories (China) Latest Developments
13.22 Jiangsu Wecare Probiotics (China)
13.22.1 Jiangsu Wecare Probiotics (China) Company Information
13.22.2 Jiangsu Wecare Probiotics (China) Next Generation Probiotics Product Portfolios and Specifications
13.22.3 Jiangsu Wecare Probiotics (China) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Jiangsu Wecare Probiotics (China) Main Business Overview
13.22.5 Jiangsu Wecare Probiotics (China) Latest Developments
13.23 Angel Yeast (China)
13.23.1 Angel Yeast (China) Company Information
13.23.2 Angel Yeast (China) Next Generation Probiotics Product Portfolios and Specifications
13.23.3 Angel Yeast (China) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Angel Yeast (China) Main Business Overview
13.23.5 Angel Yeast (China) Latest Developments
13.24 Evelo Biosciences (USA)
13.24.1 Evelo Biosciences (USA) Company Information
13.24.2 Evelo Biosciences (USA) Next Generation Probiotics Product Portfolios and Specifications
13.24.3 Evelo Biosciences (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Evelo Biosciences (USA) Main Business Overview
13.24.5 Evelo Biosciences (USA) Latest Developments
13.25 BIFIDO (South Korea)
13.25.1 BIFIDO (South Korea) Company Information
13.25.2 BIFIDO (South Korea) Next Generation Probiotics Product Portfolios and Specifications
13.25.3 BIFIDO (South Korea) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 BIFIDO (South Korea) Main Business Overview
13.25.5 BIFIDO (South Korea) Latest Developments
13.26 Cell Biotech (South Korea)
13.26.1 Cell Biotech (South Korea) Company Information
13.26.2 Cell Biotech (South Korea) Next Generation Probiotics Product Portfolios and Specifications
13.26.3 Cell Biotech (South Korea) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Cell Biotech (South Korea) Main Business Overview
13.26.5 Cell Biotech (South Korea) Latest Developments
13.27 Synlogic (USA)
13.27.1 Synlogic (USA) Company Information
13.27.2 Synlogic (USA) Next Generation Probiotics Product Portfolios and Specifications
13.27.3 Synlogic (USA) Next Generation Probiotics Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Synlogic (USA) Main Business Overview
13.27.5 Synlogic (USA) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Next Generation Probiotics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Next Generation Probiotics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Akkermansia
Table 4. Major Players of Clostridium Species
Table 5. Major Players of Bifidobacterium Species
Table 6. Major Players of Others
Table 7. Global Next Generation Probiotics Sales by Type (2021-2026) & (Tons)
Table 8. Global Next Generation Probiotics Sales Market Share by Type (2021-2026)
Table 9. Global Next Generation Probiotics Revenue by Type (2021-2026) & ($ million)
Table 10. Global Next Generation Probiotics Revenue Market Share by Type (2021-2026)
Table 11. Global Next Generation Probiotics Sale Price by Type (2021-2026) & (US$/Ton)
Table 12. Major Players of Live NGP
Table 13. Major Players of Inactivated NGP
Table 14. Major Players of Others
Table 15. Global Next Generation Probiotics Sales by Live Bacteria Status (2021-2026) & (Tons)
Table 16. Global Next Generation Probiotics Sales Market Share by Live Bacteria Status (2021-2026)
Table 17. Global Next Generation Probiotics Revenue by Live Bacteria Status (2021-2026) & ($ million)
Table 18. Global Next Generation Probiotics Revenue Market Share by Live Bacteria Status (2021-2026)
Table 19. Global Next Generation Probiotics Sale Price by Live Bacteria Status (2021-2026) & (US$/Ton)
Table 20. Major Players of Metabolic Health Targeted Therapy
Table 21. Major Players of Intestinal Inflammation Targeted Therapy
Table 22. Major Players of Immune Regulation Targeted Therapy
Table 23. Major Players of Others
Table 24. Global Next Generation Probiotics Sales by Core Functional Targeting Dimensions (2021-2026) & (Tons)
Table 25. Global Next Generation Probiotics Sales Market Share by Core Functional Targeting Dimensions (2021-2026)
Table 26. Global Next Generation Probiotics Revenue by Core Functional Targeting Dimensions (2021-2026) & ($ million)
Table 27. Global Next Generation Probiotics Revenue Market Share by Core Functional Targeting Dimensions (2021-2026)
Table 28. Global Next Generation Probiotics Sale Price by Core Functional Targeting Dimensions (2021-2026) & (US$/Ton)
Table 29. Global Next Generation Probiotics Sale by Application (2021-2026) & (Tons)
Table 30. Global Next Generation Probiotics Sale Market Share by Application (2021-2026)
Table 31. Global Next Generation Probiotics Revenue by Application (2021-2026) & ($ million)
Table 32. Global Next Generation Probiotics Revenue Market Share by Application (2021-2026)
Table 33. Global Next Generation Probiotics Sale Price by Application (2021-2026) & (US$/Ton)
Table 34. Global Next Generation Probiotics Sales by Company (2021-2026) & (Tons)
Table 35. Global Next Generation Probiotics Sales Market Share by Company (2021-2026)
Table 36. Global Next Generation Probiotics Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Next Generation Probiotics Revenue Market Share by Company (2021-2026)
Table 38. Global Next Generation Probiotics Sale Price by Company (2021-2026) & (US$/Ton)
Table 39. Key Manufacturers Next Generation Probiotics Producing Area Distribution and Sales Area
Table 40. Players Next Generation Probiotics Products Offered
Table 41. Next Generation Probiotics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Next Generation Probiotics Sales by Geographic Region (2021-2026) & (Tons)
Table 45. Global Next Generation Probiotics Sales Market Share Geographic Region (2021-2026)
Table 46. Global Next Generation Probiotics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Next Generation Probiotics Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Next Generation Probiotics Sales by Country/Region (2021-2026) & (Tons)
Table 49. Global Next Generation Probiotics Sales Market Share by Country/Region (2021-2026)
Table 50. Global Next Generation Probiotics Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Next Generation Probiotics Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Next Generation Probiotics Sales by Country (2021-2026) & (Tons)
Table 53. Americas Next Generation Probiotics Sales Market Share by Country (2021-2026)
Table 54. Americas Next Generation Probiotics Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Next Generation Probiotics Sales by Type (2021-2026) & (Tons)
Table 56. Americas Next Generation Probiotics Sales by Application (2021-2026) & (Tons)
Table 57. APAC Next Generation Probiotics Sales by Region (2021-2026) & (Tons)
Table 58. APAC Next Generation Probiotics Sales Market Share by Region (2021-2026)
Table 59. APAC Next Generation Probiotics Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Next Generation Probiotics Sales by Type (2021-2026) & (Tons)
Table 61. APAC Next Generation Probiotics Sales by Application (2021-2026) & (Tons)
Table 62. Europe Next Generation Probiotics Sales by Country (2021-2026) & (Tons)
Table 63. Europe Next Generation Probiotics Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Next Generation Probiotics Sales by Type (2021-2026) & (Tons)
Table 65. Europe Next Generation Probiotics Sales by Application (2021-2026) & (Tons)
Table 66. Middle East & Africa Next Generation Probiotics Sales by Country (2021-2026) & (Tons)
Table 67. Middle East & Africa Next Generation Probiotics Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Next Generation Probiotics Sales by Type (2021-2026) & (Tons)
Table 69. Middle East & Africa Next Generation Probiotics Sales by Application (2021-2026) & (Tons)
Table 70. Key Market Drivers & Growth Opportunities of Next Generation Probiotics
Table 71. Key Market Challenges & Risks of Next Generation Probiotics
Table 72. Key Industry Trends of Next Generation Probiotics
Table 73. Next Generation Probiotics Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Next Generation Probiotics Distributors List
Table 76. Next Generation Probiotics Customer List
Table 77. Global Next Generation Probiotics Sales Forecast by Region (2027-2032) & (Tons)
Table 78. Global Next Generation Probiotics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Next Generation Probiotics Sales Forecast by Country (2027-2032) & (Tons)
Table 80. Americas Next Generation Probiotics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Next Generation Probiotics Sales Forecast by Region (2027-2032) & (Tons)
Table 82. APAC Next Generation Probiotics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Next Generation Probiotics Sales Forecast by Country (2027-2032) & (Tons)
Table 84. Europe Next Generation Probiotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Next Generation Probiotics Sales Forecast by Country (2027-2032) & (Tons)
Table 86. Middle East & Africa Next Generation Probiotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Next Generation Probiotics Sales Forecast by Type (2027-2032) & (Tons)
Table 88. Global Next Generation Probiotics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 89. Global Next Generation Probiotics Sales Forecast by Application (2027-2032) & (Tons)
Table 90. Global Next Generation Probiotics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. Seres Therapeutics (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 92. Seres Therapeutics (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 93. Seres Therapeutics (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 94. Seres Therapeutics (USA) Main Business
Table 95. Seres Therapeutics (USA) Latest Developments
Table 96. Ferring Pharmaceuticals (Switzerland) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 97. Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Product Portfolios and Specifications
Table 98. Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 99. Ferring Pharmaceuticals (Switzerland) Main Business
Table 100. Ferring Pharmaceuticals (Switzerland) Latest Developments
Table 101. Vedanta Biosciences (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 102. Vedanta Biosciences (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 103. Vedanta Biosciences (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 104. Vedanta Biosciences (USA) Main Business
Table 105. Vedanta Biosciences (USA) Latest Developments
Table 106. Enterome (France) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 107. Enterome (France) Next Generation Probiotics Product Portfolios and Specifications
Table 108. Enterome (France) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 109. Enterome (France) Main Business
Table 110. Enterome (France) Latest Developments
Table 111. 4D Pharma (UK) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 112. 4D Pharma (UK) Next Generation Probiotics Product Portfolios and Specifications
Table 113. 4D Pharma (UK) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 114. 4D Pharma (UK) Main Business
Table 115. 4D Pharma (UK) Latest Developments
Table 116. Second Genome (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 117. Second Genome (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 118. Second Genome (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 119. Second Genome (USA) Main Business
Table 120. Second Genome (USA) Latest Developments
Table 121. AOBiome (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 122. AOBiome (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 123. AOBiome (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 124. AOBiome (USA) Main Business
Table 125. AOBiome (USA) Latest Developments
Table 126. Finch Therapeutics (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 127. Finch Therapeutics (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 128. Finch Therapeutics (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 129. Finch Therapeutics (USA) Main Business
Table 130. Finch Therapeutics (USA) Latest Developments
Table 131. MaaT Pharma (France) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 132. MaaT Pharma (France) Next Generation Probiotics Product Portfolios and Specifications
Table 133. MaaT Pharma (France) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 134. MaaT Pharma (France) Main Business
Table 135. MaaT Pharma (France) Latest Developments
Table 136. BioGaia (Sweden) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 137. BioGaia (Sweden) Next Generation Probiotics Product Portfolios and Specifications
Table 138. BioGaia (Sweden) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 139. BioGaia (Sweden) Main Business
Table 140. BioGaia (Sweden) Latest Developments
Table 141. Yakult Honsha (Japan) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 142. Yakult Honsha (Japan) Next Generation Probiotics Product Portfolios and Specifications
Table 143. Yakult Honsha (Japan) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 144. Yakult Honsha (Japan) Main Business
Table 145. Yakult Honsha (Japan) Latest Developments
Table 146. Morinaga Milk Industry (Japan) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 147. Morinaga Milk Industry (Japan) Next Generation Probiotics Product Portfolios and Specifications
Table 148. Morinaga Milk Industry (Japan) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 149. Morinaga Milk Industry (Japan) Main Business
Table 150. Morinaga Milk Industry (Japan) Latest Developments
Table 151. DuPont (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 152. DuPont (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 153. DuPont (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 154. DuPont (USA) Main Business
Table 155. DuPont (USA) Latest Developments
Table 156. Chr. Hansen (Denmark) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 157. Chr. Hansen (Denmark) Next Generation Probiotics Product Portfolios and Specifications
Table 158. Chr. Hansen (Denmark) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 159. Chr. Hansen (Denmark) Main Business
Table 160. Chr. Hansen (Denmark) Latest Developments
Table 161. Lallemand (Canada) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 162. Lallemand (Canada) Next Generation Probiotics Product Portfolios and Specifications
Table 163. Lallemand (Canada) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 164. Lallemand (Canada) Main Business
Table 165. Lallemand (Canada) Latest Developments
Table 166. Probi (Sweden) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 167. Probi (Sweden) Next Generation Probiotics Product Portfolios and Specifications
Table 168. Probi (Sweden) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 169. Probi (Sweden) Main Business
Table 170. Probi (Sweden) Latest Developments
Table 171. Novozymes (Denmark) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 172. Novozymes (Denmark) Next Generation Probiotics Product Portfolios and Specifications
Table 173. Novozymes (Denmark) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 174. Novozymes (Denmark) Main Business
Table 175. Novozymes (Denmark) Latest Developments
Table 176. Kerry Group (Ireland) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 177. Kerry Group (Ireland) Next Generation Probiotics Product Portfolios and Specifications
Table 178. Kerry Group (Ireland) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 179. Kerry Group (Ireland) Main Business
Table 180. Kerry Group (Ireland) Latest Developments
Table 181. ADM (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 182. ADM (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 183. ADM (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 184. ADM (USA) Main Business
Table 185. ADM (USA) Latest Developments
Table 186. BGI Genomics (China) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 187. BGI Genomics (China) Next Generation Probiotics Product Portfolios and Specifications
Table 188. BGI Genomics (China) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 189. BGI Genomics (China) Main Business
Table 190. BGI Genomics (China) Latest Developments
Table 191. Joinn Laboratories (China) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 192. Joinn Laboratories (China) Next Generation Probiotics Product Portfolios and Specifications
Table 193. Joinn Laboratories (China) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 194. Joinn Laboratories (China) Main Business
Table 195. Joinn Laboratories (China) Latest Developments
Table 196. Jiangsu Wecare Probiotics (China) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 197. Jiangsu Wecare Probiotics (China) Next Generation Probiotics Product Portfolios and Specifications
Table 198. Jiangsu Wecare Probiotics (China) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 199. Jiangsu Wecare Probiotics (China) Main Business
Table 200. Jiangsu Wecare Probiotics (China) Latest Developments
Table 201. Angel Yeast (China) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 202. Angel Yeast (China) Next Generation Probiotics Product Portfolios and Specifications
Table 203. Angel Yeast (China) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 204. Angel Yeast (China) Main Business
Table 205. Angel Yeast (China) Latest Developments
Table 206. Evelo Biosciences (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 207. Evelo Biosciences (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 208. Evelo Biosciences (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 209. Evelo Biosciences (USA) Main Business
Table 210. Evelo Biosciences (USA) Latest Developments
Table 211. BIFIDO (South Korea) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 212. BIFIDO (South Korea) Next Generation Probiotics Product Portfolios and Specifications
Table 213. BIFIDO (South Korea) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 214. BIFIDO (South Korea) Main Business
Table 215. BIFIDO (South Korea) Latest Developments
Table 216. Cell Biotech (South Korea) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 217. Cell Biotech (South Korea) Next Generation Probiotics Product Portfolios and Specifications
Table 218. Cell Biotech (South Korea) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 219. Cell Biotech (South Korea) Main Business
Table 220. Cell Biotech (South Korea) Latest Developments
Table 221. Synlogic (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 222. Synlogic (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 223. Synlogic (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 224. Synlogic (USA) Main Business
Table 225. Synlogic (USA) Latest Developments
Table 1. Next Generation Probiotics Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Next Generation Probiotics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Akkermansia
Table 4. Major Players of Clostridium Species
Table 5. Major Players of Bifidobacterium Species
Table 6. Major Players of Others
Table 7. Global Next Generation Probiotics Sales by Type (2021-2026) & (Tons)
Table 8. Global Next Generation Probiotics Sales Market Share by Type (2021-2026)
Table 9. Global Next Generation Probiotics Revenue by Type (2021-2026) & ($ million)
Table 10. Global Next Generation Probiotics Revenue Market Share by Type (2021-2026)
Table 11. Global Next Generation Probiotics Sale Price by Type (2021-2026) & (US$/Ton)
Table 12. Major Players of Live NGP
Table 13. Major Players of Inactivated NGP
Table 14. Major Players of Others
Table 15. Global Next Generation Probiotics Sales by Live Bacteria Status (2021-2026) & (Tons)
Table 16. Global Next Generation Probiotics Sales Market Share by Live Bacteria Status (2021-2026)
Table 17. Global Next Generation Probiotics Revenue by Live Bacteria Status (2021-2026) & ($ million)
Table 18. Global Next Generation Probiotics Revenue Market Share by Live Bacteria Status (2021-2026)
Table 19. Global Next Generation Probiotics Sale Price by Live Bacteria Status (2021-2026) & (US$/Ton)
Table 20. Major Players of Metabolic Health Targeted Therapy
Table 21. Major Players of Intestinal Inflammation Targeted Therapy
Table 22. Major Players of Immune Regulation Targeted Therapy
Table 23. Major Players of Others
Table 24. Global Next Generation Probiotics Sales by Core Functional Targeting Dimensions (2021-2026) & (Tons)
Table 25. Global Next Generation Probiotics Sales Market Share by Core Functional Targeting Dimensions (2021-2026)
Table 26. Global Next Generation Probiotics Revenue by Core Functional Targeting Dimensions (2021-2026) & ($ million)
Table 27. Global Next Generation Probiotics Revenue Market Share by Core Functional Targeting Dimensions (2021-2026)
Table 28. Global Next Generation Probiotics Sale Price by Core Functional Targeting Dimensions (2021-2026) & (US$/Ton)
Table 29. Global Next Generation Probiotics Sale by Application (2021-2026) & (Tons)
Table 30. Global Next Generation Probiotics Sale Market Share by Application (2021-2026)
Table 31. Global Next Generation Probiotics Revenue by Application (2021-2026) & ($ million)
Table 32. Global Next Generation Probiotics Revenue Market Share by Application (2021-2026)
Table 33. Global Next Generation Probiotics Sale Price by Application (2021-2026) & (US$/Ton)
Table 34. Global Next Generation Probiotics Sales by Company (2021-2026) & (Tons)
Table 35. Global Next Generation Probiotics Sales Market Share by Company (2021-2026)
Table 36. Global Next Generation Probiotics Revenue by Company (2021-2026) & ($ millions)
Table 37. Global Next Generation Probiotics Revenue Market Share by Company (2021-2026)
Table 38. Global Next Generation Probiotics Sale Price by Company (2021-2026) & (US$/Ton)
Table 39. Key Manufacturers Next Generation Probiotics Producing Area Distribution and Sales Area
Table 40. Players Next Generation Probiotics Products Offered
Table 41. Next Generation Probiotics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 42. New Products and Potential Entrants
Table 43. Market M&A Activity & Strategy
Table 44. Global Next Generation Probiotics Sales by Geographic Region (2021-2026) & (Tons)
Table 45. Global Next Generation Probiotics Sales Market Share Geographic Region (2021-2026)
Table 46. Global Next Generation Probiotics Revenue by Geographic Region (2021-2026) & ($ millions)
Table 47. Global Next Generation Probiotics Revenue Market Share by Geographic Region (2021-2026)
Table 48. Global Next Generation Probiotics Sales by Country/Region (2021-2026) & (Tons)
Table 49. Global Next Generation Probiotics Sales Market Share by Country/Region (2021-2026)
Table 50. Global Next Generation Probiotics Revenue by Country/Region (2021-2026) & ($ millions)
Table 51. Global Next Generation Probiotics Revenue Market Share by Country/Region (2021-2026)
Table 52. Americas Next Generation Probiotics Sales by Country (2021-2026) & (Tons)
Table 53. Americas Next Generation Probiotics Sales Market Share by Country (2021-2026)
Table 54. Americas Next Generation Probiotics Revenue by Country (2021-2026) & ($ millions)
Table 55. Americas Next Generation Probiotics Sales by Type (2021-2026) & (Tons)
Table 56. Americas Next Generation Probiotics Sales by Application (2021-2026) & (Tons)
Table 57. APAC Next Generation Probiotics Sales by Region (2021-2026) & (Tons)
Table 58. APAC Next Generation Probiotics Sales Market Share by Region (2021-2026)
Table 59. APAC Next Generation Probiotics Revenue by Region (2021-2026) & ($ millions)
Table 60. APAC Next Generation Probiotics Sales by Type (2021-2026) & (Tons)
Table 61. APAC Next Generation Probiotics Sales by Application (2021-2026) & (Tons)
Table 62. Europe Next Generation Probiotics Sales by Country (2021-2026) & (Tons)
Table 63. Europe Next Generation Probiotics Revenue by Country (2021-2026) & ($ millions)
Table 64. Europe Next Generation Probiotics Sales by Type (2021-2026) & (Tons)
Table 65. Europe Next Generation Probiotics Sales by Application (2021-2026) & (Tons)
Table 66. Middle East & Africa Next Generation Probiotics Sales by Country (2021-2026) & (Tons)
Table 67. Middle East & Africa Next Generation Probiotics Revenue Market Share by Country (2021-2026)
Table 68. Middle East & Africa Next Generation Probiotics Sales by Type (2021-2026) & (Tons)
Table 69. Middle East & Africa Next Generation Probiotics Sales by Application (2021-2026) & (Tons)
Table 70. Key Market Drivers & Growth Opportunities of Next Generation Probiotics
Table 71. Key Market Challenges & Risks of Next Generation Probiotics
Table 72. Key Industry Trends of Next Generation Probiotics
Table 73. Next Generation Probiotics Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Next Generation Probiotics Distributors List
Table 76. Next Generation Probiotics Customer List
Table 77. Global Next Generation Probiotics Sales Forecast by Region (2027-2032) & (Tons)
Table 78. Global Next Generation Probiotics Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Americas Next Generation Probiotics Sales Forecast by Country (2027-2032) & (Tons)
Table 80. Americas Next Generation Probiotics Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. APAC Next Generation Probiotics Sales Forecast by Region (2027-2032) & (Tons)
Table 82. APAC Next Generation Probiotics Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 83. Europe Next Generation Probiotics Sales Forecast by Country (2027-2032) & (Tons)
Table 84. Europe Next Generation Probiotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Middle East & Africa Next Generation Probiotics Sales Forecast by Country (2027-2032) & (Tons)
Table 86. Middle East & Africa Next Generation Probiotics Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. Global Next Generation Probiotics Sales Forecast by Type (2027-2032) & (Tons)
Table 88. Global Next Generation Probiotics Revenue Forecast by Type (2027-2032) & ($ millions)
Table 89. Global Next Generation Probiotics Sales Forecast by Application (2027-2032) & (Tons)
Table 90. Global Next Generation Probiotics Revenue Forecast by Application (2027-2032) & ($ millions)
Table 91. Seres Therapeutics (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 92. Seres Therapeutics (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 93. Seres Therapeutics (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 94. Seres Therapeutics (USA) Main Business
Table 95. Seres Therapeutics (USA) Latest Developments
Table 96. Ferring Pharmaceuticals (Switzerland) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 97. Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Product Portfolios and Specifications
Table 98. Ferring Pharmaceuticals (Switzerland) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 99. Ferring Pharmaceuticals (Switzerland) Main Business
Table 100. Ferring Pharmaceuticals (Switzerland) Latest Developments
Table 101. Vedanta Biosciences (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 102. Vedanta Biosciences (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 103. Vedanta Biosciences (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 104. Vedanta Biosciences (USA) Main Business
Table 105. Vedanta Biosciences (USA) Latest Developments
Table 106. Enterome (France) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 107. Enterome (France) Next Generation Probiotics Product Portfolios and Specifications
Table 108. Enterome (France) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 109. Enterome (France) Main Business
Table 110. Enterome (France) Latest Developments
Table 111. 4D Pharma (UK) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 112. 4D Pharma (UK) Next Generation Probiotics Product Portfolios and Specifications
Table 113. 4D Pharma (UK) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 114. 4D Pharma (UK) Main Business
Table 115. 4D Pharma (UK) Latest Developments
Table 116. Second Genome (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 117. Second Genome (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 118. Second Genome (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 119. Second Genome (USA) Main Business
Table 120. Second Genome (USA) Latest Developments
Table 121. AOBiome (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 122. AOBiome (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 123. AOBiome (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 124. AOBiome (USA) Main Business
Table 125. AOBiome (USA) Latest Developments
Table 126. Finch Therapeutics (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 127. Finch Therapeutics (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 128. Finch Therapeutics (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 129. Finch Therapeutics (USA) Main Business
Table 130. Finch Therapeutics (USA) Latest Developments
Table 131. MaaT Pharma (France) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 132. MaaT Pharma (France) Next Generation Probiotics Product Portfolios and Specifications
Table 133. MaaT Pharma (France) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 134. MaaT Pharma (France) Main Business
Table 135. MaaT Pharma (France) Latest Developments
Table 136. BioGaia (Sweden) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 137. BioGaia (Sweden) Next Generation Probiotics Product Portfolios and Specifications
Table 138. BioGaia (Sweden) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 139. BioGaia (Sweden) Main Business
Table 140. BioGaia (Sweden) Latest Developments
Table 141. Yakult Honsha (Japan) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 142. Yakult Honsha (Japan) Next Generation Probiotics Product Portfolios and Specifications
Table 143. Yakult Honsha (Japan) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 144. Yakult Honsha (Japan) Main Business
Table 145. Yakult Honsha (Japan) Latest Developments
Table 146. Morinaga Milk Industry (Japan) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 147. Morinaga Milk Industry (Japan) Next Generation Probiotics Product Portfolios and Specifications
Table 148. Morinaga Milk Industry (Japan) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 149. Morinaga Milk Industry (Japan) Main Business
Table 150. Morinaga Milk Industry (Japan) Latest Developments
Table 151. DuPont (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 152. DuPont (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 153. DuPont (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 154. DuPont (USA) Main Business
Table 155. DuPont (USA) Latest Developments
Table 156. Chr. Hansen (Denmark) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 157. Chr. Hansen (Denmark) Next Generation Probiotics Product Portfolios and Specifications
Table 158. Chr. Hansen (Denmark) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 159. Chr. Hansen (Denmark) Main Business
Table 160. Chr. Hansen (Denmark) Latest Developments
Table 161. Lallemand (Canada) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 162. Lallemand (Canada) Next Generation Probiotics Product Portfolios and Specifications
Table 163. Lallemand (Canada) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 164. Lallemand (Canada) Main Business
Table 165. Lallemand (Canada) Latest Developments
Table 166. Probi (Sweden) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 167. Probi (Sweden) Next Generation Probiotics Product Portfolios and Specifications
Table 168. Probi (Sweden) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 169. Probi (Sweden) Main Business
Table 170. Probi (Sweden) Latest Developments
Table 171. Novozymes (Denmark) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 172. Novozymes (Denmark) Next Generation Probiotics Product Portfolios and Specifications
Table 173. Novozymes (Denmark) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 174. Novozymes (Denmark) Main Business
Table 175. Novozymes (Denmark) Latest Developments
Table 176. Kerry Group (Ireland) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 177. Kerry Group (Ireland) Next Generation Probiotics Product Portfolios and Specifications
Table 178. Kerry Group (Ireland) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 179. Kerry Group (Ireland) Main Business
Table 180. Kerry Group (Ireland) Latest Developments
Table 181. ADM (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 182. ADM (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 183. ADM (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 184. ADM (USA) Main Business
Table 185. ADM (USA) Latest Developments
Table 186. BGI Genomics (China) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 187. BGI Genomics (China) Next Generation Probiotics Product Portfolios and Specifications
Table 188. BGI Genomics (China) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 189. BGI Genomics (China) Main Business
Table 190. BGI Genomics (China) Latest Developments
Table 191. Joinn Laboratories (China) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 192. Joinn Laboratories (China) Next Generation Probiotics Product Portfolios and Specifications
Table 193. Joinn Laboratories (China) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 194. Joinn Laboratories (China) Main Business
Table 195. Joinn Laboratories (China) Latest Developments
Table 196. Jiangsu Wecare Probiotics (China) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 197. Jiangsu Wecare Probiotics (China) Next Generation Probiotics Product Portfolios and Specifications
Table 198. Jiangsu Wecare Probiotics (China) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 199. Jiangsu Wecare Probiotics (China) Main Business
Table 200. Jiangsu Wecare Probiotics (China) Latest Developments
Table 201. Angel Yeast (China) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 202. Angel Yeast (China) Next Generation Probiotics Product Portfolios and Specifications
Table 203. Angel Yeast (China) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 204. Angel Yeast (China) Main Business
Table 205. Angel Yeast (China) Latest Developments
Table 206. Evelo Biosciences (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 207. Evelo Biosciences (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 208. Evelo Biosciences (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 209. Evelo Biosciences (USA) Main Business
Table 210. Evelo Biosciences (USA) Latest Developments
Table 211. BIFIDO (South Korea) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 212. BIFIDO (South Korea) Next Generation Probiotics Product Portfolios and Specifications
Table 213. BIFIDO (South Korea) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 214. BIFIDO (South Korea) Main Business
Table 215. BIFIDO (South Korea) Latest Developments
Table 216. Cell Biotech (South Korea) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 217. Cell Biotech (South Korea) Next Generation Probiotics Product Portfolios and Specifications
Table 218. Cell Biotech (South Korea) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 219. Cell Biotech (South Korea) Main Business
Table 220. Cell Biotech (South Korea) Latest Developments
Table 221. Synlogic (USA) Basic Information, Next Generation Probiotics Manufacturing Base, Sales Area and Its Competitors
Table 222. Synlogic (USA) Next Generation Probiotics Product Portfolios and Specifications
Table 223. Synlogic (USA) Next Generation Probiotics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2021-2026)
Table 224. Synlogic (USA) Main Business
Table 225. Synlogic (USA) Latest Developments
LIST OF FIGURES
Figure 1. Picture of Next Generation Probiotics
Figure 2. Next Generation Probiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Next Generation Probiotics Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Next Generation Probiotics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Next Generation Probiotics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Next Generation Probiotics Sales Market Share by Country/Region (2025)
Figure 10. Next Generation Probiotics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Akkermansia
Figure 12. Product Picture of Clostridium Species
Figure 13. Product Picture of Bifidobacterium Species
Figure 14. Product Picture of Others
Figure 15. Global Next Generation Probiotics Sales Market Share by Type in 2026
Figure 16. Global Next Generation Probiotics Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Live NGP
Figure 18. Product Picture of Inactivated NGP
Figure 19. Product Picture of Others
Figure 20. Global Next Generation Probiotics Sales Market Share by Live Bacteria Status in 2026
Figure 21. Global Next Generation Probiotics Revenue Market Share by Live Bacteria Status (2021-2026)
Figure 22. Product Picture of Metabolic Health Targeted Therapy
Figure 23. Product Picture of Intestinal Inflammation Targeted Therapy
Figure 24. Product Picture of Immune Regulation Targeted Therapy
Figure 25. Product Picture of Others
Figure 26. Global Next Generation Probiotics Sales Market Share by Core Functional Targeting Dimensions in 2026
Figure 27. Global Next Generation Probiotics Revenue Market Share by Core Functional Targeting Dimensions (2021-2026)
Figure 28. Next Generation Probiotics Consumed in Pharmaceuticals and Biotherapy Industry
Figure 29. Global Next Generation Probiotics Market: Pharmaceuticals and Biotherapy Industry (2021-2026) & (Tons)
Figure 30. Next Generation Probiotics Consumed in Dietary Supplements and Functional Foods Industry
Figure 31. Global Next Generation Probiotics Market: Dietary Supplements and Functional Foods Industry (2021-2026) & (Tons)
Figure 32. Next Generation Probiotics Consumed in Food and Beverage Industry
Figure 33. Global Next Generation Probiotics Market: Food and Beverage Industry (2021-2026) & (Tons)
Figure 34. Next Generation Probiotics Consumed in Others
Figure 35. Global Next Generation Probiotics Market: Others (2021-2026) & (Tons)
Figure 36. Global Next Generation Probiotics Sale Market Share by Application (2025)
Figure 37. Global Next Generation Probiotics Revenue Market Share by Application in 2025
Figure 38. Next Generation Probiotics Sales by Company in 2025 (Tons)
Figure 39. Global Next Generation Probiotics Sales Market Share by Company in 2025
Figure 40. Next Generation Probiotics Revenue by Company in 2025 ($ millions)
Figure 41. Global Next Generation Probiotics Revenue Market Share by Company in 2025
Figure 42. Global Next Generation Probiotics Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Next Generation Probiotics Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Next Generation Probiotics Sales 2021-2026 (Tons)
Figure 45. Americas Next Generation Probiotics Revenue 2021-2026 ($ millions)
Figure 46. APAC Next Generation Probiotics Sales 2021-2026 (Tons)
Figure 47. APAC Next Generation Probiotics Revenue 2021-2026 ($ millions)
Figure 48. Europe Next Generation Probiotics Sales 2021-2026 (Tons)
Figure 49. Europe Next Generation Probiotics Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Next Generation Probiotics Sales 2021-2026 (Tons)
Figure 51. Middle East & Africa Next Generation Probiotics Revenue 2021-2026 ($ millions)
Figure 52. Americas Next Generation Probiotics Sales Market Share by Country in 2025
Figure 53. Americas Next Generation Probiotics Revenue Market Share by Country (2021-2026)
Figure 54. Americas Next Generation Probiotics Sales Market Share by Type (2021-2026)
Figure 55. Americas Next Generation Probiotics Sales Market Share by Application (2021-2026)
Figure 56. United States Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Next Generation Probiotics Sales Market Share by Region in 2025
Figure 61. APAC Next Generation Probiotics Revenue Market Share by Region (2021-2026)
Figure 62. APAC Next Generation Probiotics Sales Market Share by Type (2021-2026)
Figure 63. APAC Next Generation Probiotics Sales Market Share by Application (2021-2026)
Figure 64. China Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 68. India Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Next Generation Probiotics Sales Market Share by Country in 2025
Figure 72. Europe Next Generation Probiotics Revenue Market Share by Country (2021-2026)
Figure 73. Europe Next Generation Probiotics Sales Market Share by Type (2021-2026)
Figure 74. Europe Next Generation Probiotics Sales Market Share by Application (2021-2026)
Figure 75. Germany Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 76. France Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Next Generation Probiotics Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Next Generation Probiotics Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Next Generation Probiotics Sales Market Share by Application (2021-2026)
Figure 83. Egypt Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Next Generation Probiotics in 2026
Figure 89. Manufacturing Process Analysis of Next Generation Probiotics
Figure 90. Industry Chain Structure of Next Generation Probiotics
Figure 91. Channels of Distribution
Figure 92. Global Next Generation Probiotics Sales Market Forecast by Region (2027-2032)
Figure 93. Global Next Generation Probiotics Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Next Generation Probiotics Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Next Generation Probiotics Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Next Generation Probiotics Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Next Generation Probiotics Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Next Generation Probiotics
Figure 2. Next Generation Probiotics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Next Generation Probiotics Sales Growth Rate 2021-2032 (Tons)
Figure 7. Global Next Generation Probiotics Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Next Generation Probiotics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Next Generation Probiotics Sales Market Share by Country/Region (2025)
Figure 10. Next Generation Probiotics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Akkermansia
Figure 12. Product Picture of Clostridium Species
Figure 13. Product Picture of Bifidobacterium Species
Figure 14. Product Picture of Others
Figure 15. Global Next Generation Probiotics Sales Market Share by Type in 2026
Figure 16. Global Next Generation Probiotics Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Live NGP
Figure 18. Product Picture of Inactivated NGP
Figure 19. Product Picture of Others
Figure 20. Global Next Generation Probiotics Sales Market Share by Live Bacteria Status in 2026
Figure 21. Global Next Generation Probiotics Revenue Market Share by Live Bacteria Status (2021-2026)
Figure 22. Product Picture of Metabolic Health Targeted Therapy
Figure 23. Product Picture of Intestinal Inflammation Targeted Therapy
Figure 24. Product Picture of Immune Regulation Targeted Therapy
Figure 25. Product Picture of Others
Figure 26. Global Next Generation Probiotics Sales Market Share by Core Functional Targeting Dimensions in 2026
Figure 27. Global Next Generation Probiotics Revenue Market Share by Core Functional Targeting Dimensions (2021-2026)
Figure 28. Next Generation Probiotics Consumed in Pharmaceuticals and Biotherapy Industry
Figure 29. Global Next Generation Probiotics Market: Pharmaceuticals and Biotherapy Industry (2021-2026) & (Tons)
Figure 30. Next Generation Probiotics Consumed in Dietary Supplements and Functional Foods Industry
Figure 31. Global Next Generation Probiotics Market: Dietary Supplements and Functional Foods Industry (2021-2026) & (Tons)
Figure 32. Next Generation Probiotics Consumed in Food and Beverage Industry
Figure 33. Global Next Generation Probiotics Market: Food and Beverage Industry (2021-2026) & (Tons)
Figure 34. Next Generation Probiotics Consumed in Others
Figure 35. Global Next Generation Probiotics Market: Others (2021-2026) & (Tons)
Figure 36. Global Next Generation Probiotics Sale Market Share by Application (2025)
Figure 37. Global Next Generation Probiotics Revenue Market Share by Application in 2025
Figure 38. Next Generation Probiotics Sales by Company in 2025 (Tons)
Figure 39. Global Next Generation Probiotics Sales Market Share by Company in 2025
Figure 40. Next Generation Probiotics Revenue by Company in 2025 ($ millions)
Figure 41. Global Next Generation Probiotics Revenue Market Share by Company in 2025
Figure 42. Global Next Generation Probiotics Sales Market Share by Geographic Region (2021-2026)
Figure 43. Global Next Generation Probiotics Revenue Market Share by Geographic Region in 2025
Figure 44. Americas Next Generation Probiotics Sales 2021-2026 (Tons)
Figure 45. Americas Next Generation Probiotics Revenue 2021-2026 ($ millions)
Figure 46. APAC Next Generation Probiotics Sales 2021-2026 (Tons)
Figure 47. APAC Next Generation Probiotics Revenue 2021-2026 ($ millions)
Figure 48. Europe Next Generation Probiotics Sales 2021-2026 (Tons)
Figure 49. Europe Next Generation Probiotics Revenue 2021-2026 ($ millions)
Figure 50. Middle East & Africa Next Generation Probiotics Sales 2021-2026 (Tons)
Figure 51. Middle East & Africa Next Generation Probiotics Revenue 2021-2026 ($ millions)
Figure 52. Americas Next Generation Probiotics Sales Market Share by Country in 2025
Figure 53. Americas Next Generation Probiotics Revenue Market Share by Country (2021-2026)
Figure 54. Americas Next Generation Probiotics Sales Market Share by Type (2021-2026)
Figure 55. Americas Next Generation Probiotics Sales Market Share by Application (2021-2026)
Figure 56. United States Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 57. Canada Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 58. Mexico Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 59. Brazil Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 60. APAC Next Generation Probiotics Sales Market Share by Region in 2025
Figure 61. APAC Next Generation Probiotics Revenue Market Share by Region (2021-2026)
Figure 62. APAC Next Generation Probiotics Sales Market Share by Type (2021-2026)
Figure 63. APAC Next Generation Probiotics Sales Market Share by Application (2021-2026)
Figure 64. China Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 65. Japan Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 66. South Korea Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 67. Southeast Asia Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 68. India Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 69. Australia Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 70. China Taiwan Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 71. Europe Next Generation Probiotics Sales Market Share by Country in 2025
Figure 72. Europe Next Generation Probiotics Revenue Market Share by Country (2021-2026)
Figure 73. Europe Next Generation Probiotics Sales Market Share by Type (2021-2026)
Figure 74. Europe Next Generation Probiotics Sales Market Share by Application (2021-2026)
Figure 75. Germany Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 76. France Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 77. UK Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 78. Italy Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 79. Russia Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 80. Middle East & Africa Next Generation Probiotics Sales Market Share by Country (2021-2026)
Figure 81. Middle East & Africa Next Generation Probiotics Sales Market Share by Type (2021-2026)
Figure 82. Middle East & Africa Next Generation Probiotics Sales Market Share by Application (2021-2026)
Figure 83. Egypt Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 84. South Africa Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 85. Israel Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 86. Turkey Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 87. GCC Countries Next Generation Probiotics Revenue Growth 2021-2026 ($ millions)
Figure 88. Manufacturing Cost Structure Analysis of Next Generation Probiotics in 2026
Figure 89. Manufacturing Process Analysis of Next Generation Probiotics
Figure 90. Industry Chain Structure of Next Generation Probiotics
Figure 91. Channels of Distribution
Figure 92. Global Next Generation Probiotics Sales Market Forecast by Region (2027-2032)
Figure 93. Global Next Generation Probiotics Revenue Market Share Forecast by Region (2027-2032)
Figure 94. Global Next Generation Probiotics Sales Market Share Forecast by Type (2027-2032)
Figure 95. Global Next Generation Probiotics Revenue Market Share Forecast by Type (2027-2032)
Figure 96. Global Next Generation Probiotics Sales Market Share Forecast by Application (2027-2032)
Figure 97. Global Next Generation Probiotics Revenue Market Share Forecast by Application (2027-2032)
